Expression and functional analyses of breast cancer resistance protein in lung cancer

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 3052-3057

  Kawabata, Shigeru ^a   Oka, Mikio ^a,b   Soda, Hiroshi ^a   Shiozawa, Ken ^a   Nakatomi, Katsumi ^a   Tsurutani, Junji ^a   Nakamura, Yoichi ^a   Doi, Seiji ^a   Kitazaki, Takeshi ^a   Sugahara, Kazuyuki ^a   Yamada, Yasuaki ^a   Kamihira, Shimeru ^a   Kohno, Shigeru ^a,b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; IRINOTECAN; MITOXANTRONE; TETRAZOLIUM; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG SENSITIVITY; DRUG TRANSPORT; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CAMPTOTHECIN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; MITOXANTRONE; NEOPLASM PROTEINS; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOPOTECAN;

EID: 12444261717     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gottesman, M. M. Mechanisms of cancer drug resistance. Annu. Rev. Med., 53: 615-627, 2002.
2. Borst, P., and Elferink, R. O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem., 71: 537-592, 2002.
3. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998.
4. Allen, J. D., Brinkhuis, R. F., Wijnholds, J., and Schinkel, A. H. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res., 59: 4237-4241, 1999.
5. Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp-Helmers, M. C., Floot, B. G., and Schellens, J. H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res., 59: 4559-4563, 1999.
6. Nakatomi, K., Yoshikawa, M., Oka, M., Ikegami, Y., Hayasaka, S., Sano, K., Shiozawa, K., Kawabata, S., Soda, H., Tanabe, S., and Kohno, S. Transport of 7-ethyl-10hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun., 288: 827-832, 2001.
7. Fukuda, M., Oka, M., Soda, H., Terashi, K., Kawabata, S., Nakatomi, K., Takatani, H., Tsurutani, J., Tsukamoto, K., Noguchi, Y., Fukuda, M., Kinoshita, A., and Kohno, S. Phase I study of irinotecan combined with carboplatin in previously untreated solid cancers. Clin. Cancer Res., 5: 3963-3969, 1999.
8. Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., Yamamoto, S., and Saijo, N. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N. Engl. J. Med., 346: 85-91, 2002.
9. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van De Vijver, M. J., Scheper, R. J., and Schellens, J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res., 61: 3458-3464, 2001.
10. Scheffer, G. L., Pijnenborg, A. C., Smit, E. F., Muller, M., Postma, D. S., Timens, W., van der Valk, P., de Vries, E. G., and Scheper, R. J. Multidrug resistance related molecules in human and murine lung. J. Clin. Pathol. (Lond.), 55: 332-339, 2002.
11. Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P., and Doyle, L. A. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J. Natl. Cancer Inst. (Bethesda), 91: 429-433, 1999.
12. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., and Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 59: 8-13, 1999.
13. Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., Kamihira, S., Doyle, L. A., Ross, D. D., and Kohno, S. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem. Biophys. Res. Commun., 280: 1216-1223, 2001.
14. Ross, D. D., Karp, J. E., Chen, T. T., and Doyle, L. A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood, 96: 365-368, 2000.
15. Faneyte, I. F., Kristel, P. M. P., Maliepaard, M., Scheffer, G. L., Scheper, R. J., Schellens, J. H. M., and van de Vijver, M. J. Expression of the breast cancer resistance protein in breast cancer. Clin. Cancer Res., 8: 1068-1074, 2001.
16. van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Muller, M., Bates, S. E., Scheper, R. J., and de Vries, E. G. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood, 99: 3763-3770, 2002.
17. van den Heuvel-Eibrink, M. M., Wiemer, E. A., Prins, A., Meijerink, J. P., Vossebeld, P. J., van der Holt, B., Pieters, R., and Sonneveld, P. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia (Baltimore), 16: 833-839, 2002.
18. Joto, N., Ishii, M., Minami, M., Kuga, H., Mitsui, I., and Tohgo, A. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int. J. Cancer, 72: 680-686, 1997.
19. Nakatomi, K., Oka, M., Shiozawa, K., Kawabata, S., Tsurutani, J., Nakamura, Y., Soda, H., and Kohno, S. Mutation and quantitative analysis of breast cancer resistance protein (BCRP/MXR/ABCG2) gene in lung cancer cells. Proc. Am. Assoc. Cancer Res., 43: 778, 2002.
20. Özvegy, C., Váradi, A., and Sarkadi, B. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter: modulation of substrate specificity by a point mutation. J. Biol. Chem., 277: 47980-47990, 2002.
21. Shiozawa, K., Oka, M., Nakatomi, K., Yoshikawa, M., Ikegami, Y., Kawabata, S., Soda, H., Tsurutani, J., Murase, K., and Kohno, S. Effective reversal of breast cancer resistant protein (BCRP)-mediated drug resistance by novobiocin. Proc. Am. Assoc. Cancer Res., 43: 495, 2002.
22. Narasaki, F., Oka, M., Fukuda, M., Ikeda, K., Terashi, K., Takatani, H., Nakamura, T., Soda, H., and Kohno, S. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells. Anticancer Res., 17: 3493-3497, 1997.
23. Kobayashi, K., Hino, M., Fukuoka, M., Takeuchi, K., Furuse, K., Yoneda, S., Hasegawa, K., Noda, K., Kinoshita, H., Kimura, I., Taguchi, T., Kanamaru, R., Horikoshi, N., and Niitani, H. Phase I studies of nogitecan hydrochloride for Japanese. Int. J. Clin. Oncol., 7: 177-186, 2002.
24. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
25. Young, L. C., Campling, B. G., Cole, S. P., Deeley, R. G., and Gerlach, J. H. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin. Cancer Res., 7: 1798-1804, 2001.